Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-06-18

Clinical Trial Update: Prazosin as an Antimanic Agent in Severe Mania or Mixed States [NA]

View source ↗

Summary

A clinical trial evaluating prazosin as an antimanic agent in bipolar mania or mixed states has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Prazosin (prazosin)

Snippet

Sponsor: Mclean Hospital | Conditions: Bipolar, Mania, Bipolar, Mixed State | NA | Status: WITHDRAWN